| scholarly article | Q13442814 |
| P50 | author | Claudio Rapezzi | Q41724618 |
| Ornella Leone | Q42843529 | ||
| P2093 | author name string | L Lovato | |
| R Fattori | |||
| A Branzi | |||
| F Salvi | |||
| L Riva | |||
| L Bacchi-Reggiani | |||
| T Piva | |||
| E Perugini | |||
| P2860 | cites work | Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction | Q31988500 |
| Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis | Q34023787 | ||
| Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association | Q34111674 | ||
| Cardiovascular magnetic resonance in cardiac amyloidosis | Q38515487 | ||
| Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. | Q38518827 | ||
| Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance | Q38520098 | ||
| Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. | Q38520406 | ||
| Images in cardiovascular medicine. Myocardial fibrosis in glycogen storage disease type III. | Q38521040 | ||
| Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms | Q38776803 | ||
| The systemic amyloidoses | Q41596634 | ||
| MRI evaluation of amyloid myopathy | Q43524264 | ||
| Demonstration of restrictive ventricular physiology by Doppler echocardiography | Q44315098 | ||
| Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. | Q50772826 | ||
| Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. | Q52954584 | ||
| Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy | Q57013668 | ||
| Magnetic Resonance Imaging in Primary Amyloidosis | Q58306494 | ||
| Electrocardiographic observations in severe aortic valve stenosis: correlative necropsy study to clinical, hemodynamic,, and ECG variables demonstrating relation of 12-lead QRS amplitude to peak systolic transaortic pressure gradient | Q70563662 | ||
| Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium | Q70600676 | ||
| Clinical significance of histopathologic patterns of cardiac amyloidosis | Q71436818 | ||
| The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction | Q73191075 | ||
| Comparison of usefulness between exercise capacity and echocardiographic indexes of left ventricular function in cardiac amyloidosis | Q73200665 | ||
| Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death? | Q73383444 | ||
| Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis | Q74593974 | ||
| Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy | Q78726625 | ||
| Amyloidosis and endomyocardial biopsy: Correlation of extent and pattern of deposition with amyloid immunophenotype in 100 cases | Q87070765 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gadolinium | Q1832 |
| P304 | page(s) | 343-349 | |
| P577 | publication date | 2005-06-06 | |
| P1433 | published in | Heart | Q856338 |
| P1476 | title | Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance | |
| P478 | volume | 92 |
| Q90265678 | 3D myocardial deformation analysis from cine MRI as a marker of amyloid protein burden in cardiac amyloidosis: validation versus T1 mapping |
| Q42987768 | An unusual case of cardiac amyloidosis. |
| Q42987784 | Author reply--an unusual case of cardiac amyloidosis |
| Q37633748 | CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis |
| Q55271656 | Cardiac Amyloidosis Diagnosis with Magnetic Resonance Imaging: A Case Report. |
| Q39320411 | Cardiac Amyloidosis: Diagnosis and Treatment Strategies |
| Q37899075 | Cardiac amyloidosis: the heart of the matter |
| Q56986003 | Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis |
| Q30432349 | Cardiac magnetic resonance imaging for the investigation of cardiovascular disorders. Part 1: current applications |
| Q37020261 | Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis |
| Q41686949 | Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging. |
| Q51228133 | Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease. |
| Q59793119 | Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers |
| Q37186950 | Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis |
| Q48667105 | Early Impairment of Cardiac Function and Asynchronization of Systemic Amyloidosis with Preserved Ejection Fraction Using Two-Dimensional Speckle Tracking Echocardiography |
| Q38126089 | Emerging concepts for myocardial late gadolinium enhancement MRI. |
| Q56031907 | Familial and Senile Amyloidosis Caused by Transthyretin |
| Q34328734 | Guideline of transthyretin-related hereditary amyloidosis for clinicians. |
| Q36367005 | Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management. |
| Q38136289 | How to diagnose amyloidosis. |
| Q37248274 | Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance |
| Q38547033 | Improving strategies for the diagnosis of cardiac amyloidosis |
| Q37399628 | Incidence, diagnosis and prognosis of cardiac amyloidosis |
| Q58450389 | Late Gadolinium Enhancement Imaging |
| Q46526071 | Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings |
| Q41186489 | Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia |
| Q37333390 | MRI assessment of cardiac amyloidosis: experience of six cases with review of the current literature |
| Q87344032 | MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease |
| Q36666474 | Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: current applications and future perspectives |
| Q37154775 | Magnetic resonance imaging of cardiovascular fibrosis and inflammation: from clinical practice to animal studies and back |
| Q38450940 | Monitoring systemic amyloidosis using MRI measurements of the extracellular volume fraction |
| Q87797451 | Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis |
| Q92489456 | New insights into the clinical evaluation of hereditary transthyretin amyloidosis patients: a single center's experience |
| Q56981390 | New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis |
| Q38532386 | Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology |
| Q58125154 | Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective study |
| Q84749662 | Noninvasive diagnosis of cardiac amyloidosis by MRI and echochardiography |
| Q34417492 | Noninvasive molecular imaging of cell death in myocardial infarction using 111In-GSAO. |
| Q41272712 | Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics. |
| Q52894311 | Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis. |
| Q39754493 | Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study |
| Q34340740 | Senile systemic amyloidosis: clinical features at presentation and outcome |
| Q48404782 | Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis |
| Q88711734 | The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure |
| Q34677424 | The relative atrial volume ratio and late gadolinium enhancement provide additive information to differentiate constrictive pericarditis from restrictive cardiomyopathy. |
| Q37822294 | The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy |
| Q48660637 | The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis |
| Q38517905 | The transthyretin amyloidoses: advances in therapy |
| Q37755977 | Transthyretin-related amyloidoses and the heart: a clinical overview |
Search more.